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Abstract
Background: Overweight and obesity during pregnancy raise the risk of gestational diabetes and birth
complications. Lifestyle factors like physical activity may decrease these risks through beneficial effects on glucose
homeostasis. Here we examined physical activity patterns and their relationships with measures of glucose
homeostasis in late pregnancy compared to non-pregnant women.
Methods: Normal weight and overweight women without diabetes (N = 108; aged 25-35 years) were studied; 35
were pregnant (in gestational weeks 28-32) and 73 were non-pregnant.
Insulin sensitivity and b-cell response were estimated from an oral glucose tolerance test. Physical activity was
measured during 10-days of free-living using a combined heart rate sensor and accelerometer. Total (TEE), resting
(REE), and physical activity (PAEE) energy expenditure were measured using doubly-labeled water and expired gas
indirect calorimetry.
Results: Total activity was associated with reduced first-phase insulin response in both pregnant (Regression
r
2 = 0.11; Spearman r = -0.47; p = 0.007) and non-pregnant women (Regression r
2 = 0.11 Spearman; r = -0.36;
p = 0.002). Relative to non-pregnant women, pregnant women were estimated to have secreted 67% more insulin
and had 10% lower fasting glucose than non-pregnant women. Pregnant women spent 13% more time sedentary,
71% less time in moderate-to-vigorous intensity activity, had 44% lower objectively measured total activity, and
12% lower PAEE than non-pregnant women. Correlations did not differ significantly for any comparison between
physical activity subcomponents and measures of insulin sensitivity or secretion.
Conclusions: Our findings suggest that physical activity conveys similar benefits on glucose homeostasis in
pregnant and non-pregnant women, despite differences in subcomponents of physical activity.
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Background
During late pregnancy insulin sensitivity declines by 40-
60% compared to pre-gestational insulin sensitivity [1]
and insulin secretion typically increases, which is a com-
pensatory response and helps maintain glucose homeos-
tasis [1]. The mechanisms driving insulin resistance in a
healthy pregnancy, as well as in a pregnancy complicated
by hyperglycemia, are complex and differ from the non-
pregnant scenario [2]. In addition to a decline in insulin
sensitivity, other features of pregnancy such as changes
in diet or physical activity can impair systemic glucose
regulation. One common barrier to physical activity in
pregnant women is pregnancy-related pain; the preva-
lence of pelvic girdle pain or low back pain in pregnancy
has been reported to be as high as 45% [3].
Physical activity is a complex exposure with multiple
subcomponents. Some of the subcomponents measured
with objective methods such as accelerometers have
been shown to be associated with glucose regulation in
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assessed by accelerometry is positively associated with
insulin sensitivity in non-pregnant adults [4]. All studies
to date examining associations between physical activity
and glucose regulation during pregnancy have relied on
subjective self-report measures of physical activity.
Self-reported vigorous activity prior to pregnancy and
light-to-moderate activity during pregnancy are
associated with a reduced risk of hyperglycemia during
pregnancy [5].
Regular physical activity is known to improve periph-
eral insulin sensitivity [6] and, in non-pregnant adults,
increasing insulin sensitivity through lifestyle modifica-
tion improves glucose tolerance and may aid in preser-
ving b-cell function [7]. However, it is unclear if the
effects of physical activity on glucose homeostasis
o b s e r v e do u t s i d ep r e g n a n c ya r et h es a m ea sd u r i n g
pregnancy. Although lifestyle modification such as diet
and physical activity to limit excessive weight gain is the
front-line therapy for GDM [8], it is unknown if lifestyle
modification can prevent GDM. Several intervention
studies have been performed in pregnancy [9-12].
Whilst some of these studiess o u g h tt oq u a n t i f yt h e
amount and intensity of exercise performed during the
hours of the intervention, none to date has adequately
assessed overall physical activity energy expenditure
(PAEE) or non-exercise activity. This point is important,
as people undergoing exercise interventions may com-
pensate by reducing physical activity during other parts
of the day [13]. Thus, there is a requirement for studies
that define the appropriate dose, intensity, and mode of
physical activity during pregnancy to maintain optimal
weight gain and glucose regulation, so that guidelines to
help prevent GDM are evidence-based.
A goal of this study was to explore the relationships
between subcomponents of physical activity (e.g., PAEE,
total activity, time spent in moderate-to-vigorous inten-
sity activity, and sedentary time) and estimates of insulin
sensitivity and b-cell responses in pregnant and non-
pregnant women. Most importantly, we sought to deter-
mine if the relationships between subcomponents of
physical activity and estimates of insulin sensitivity and
b-cell responses differ in pregnant versus non-pregnant
women.
Methods
Participants
A total of 108 women were studied at the baseline visit,
of whom 35 were pregnant and 73 were not pregnant.
Non-pregnancy was confirmed by a urine pregnancy test
upon arrival at the Clinical Research Center at Umeå
University Hospital. Pregnant and non-pregnant women
were broadly matched on demographic characteristics
such as age, weight and place of residency. All women
lived in eastern Västerbotten, the second most northerly
county in Sweden.
Women were recruited through advertisements in
local media and with the assistance of midwives within
antenatal care. Pregnant women were recruited during
the first or second trimester (at 8-16 weeks of gestation)
and studied during the third trimester (at 28-32 weeks
of gestation). All pregnant women had successful deliv-
eries, one of which yielded twins. Information concern-
ing the delivery was collected with the mothers’ consent
from the hospital-based register on antenatal care and
delivery care. All participants provided written informed
consent. The research conformed to the Helsinki
Declaration and all local laws and the study protocol
was approved by the Regional Ethical Review Board in
Umeå.
Assessment of body composition
Height was measured to the nearest 0.5 cm using a cali-
brated wall-mounted stadiometer and weight to the
nearest 0.1 kg using a calibrated digital scale. Body mass
index (BMI) was calculated as weight (kg) divided by
height squared (m
2)( k g / m
2). Body composition (fat and
fat-free mass) was estimated from the doubly-labeled
water (DLW) measurement using the isotope dilution
method [14]. Total body water was calculated as the
average of the linearly regressed isotope dilution spaces
at time 0, correcting by 1.01 and 1.04, respectively, to
account for the exchange of isotopes with non-aqueous
components within the body. Fat-free mass was then
calculated by dividing by the hydration factor of 0.722
and 0.747 for non-pregnant and pregnant women,
respectively, with the difference between body weight
and lean tissue equating to the fat mass [15].
Energy expenditure
Resting energy expenditure (REE) was estimated using
expired gas indirect calorimetry during 30 minutes of
reclined rest using a ventilated hood system (Deltatrac
II, Datex-Ohmeda, Inc., WI, USA). Total energy expen-
diture (TEE) was estimated during ten days of free-living
using DLW. For this measurement, participants received
a body weight dependent oral dose of stable isotope
((0.07 g
2H2O and 0.174 g H2
18O)/kg body weight). A
pre-dose urine sample was obtained at the Clinical
Research Center after which a urine sample was col-
lected every day during the following ten days; partici-
pants noted the time of each sample collection in a log.
Samples were stored at 4-8°C until returned to the Clin-
ical Research Center, where they were stored at -20°C
pending analysis. Urine samples were analyzed at the
MRC Human Nutrition Research, University of Cam-
bridge, Cambridge, UK, using methods described in
detail elsewhere [16]. Briefly, measurements of H/H
Gradmark et al. BMC Pregnancy and Childbirth 2011, 11:44
http://www.biomedcentral.com/1471-2393/11/44
Page 2 of 8ratios were made by dual inlet isotope-ratio mass spec-
troscopy (IRMS) (Sira 10, VG Isogas, Middlewich, UK).
Samples (0.4 ml) were aliqoted into nominally 2.5 mL
vials, and a platinum catalyst added. The vials were
flush filled with hydrogen gas and equilibrated at 22°C
for 6 hours before analysis. All measurements were cal-
culated relative to Vienna standard mean ocean water
(V-SMOW) using international standards. Measure-
ments of
18O/
16O ratios were made using an AP2003
continuous flow IRMS (Analytical Precision Ltd, North-
wich, Cheshire, UK). Samples (0.5 ml) were flush filled
with 5% CO2 in nitrogen and then equilibrated over-
night. Sample enrichments were expressed relative to V-
SMOW, using laboratory standards. TEE was calculated
as described by Coward et al. [17] from slopes and
intercepts of the isotope disappearance curves based on
urine samples collected at days 1-3 and 8-10. Respira-
tory quotient (RQ) was assumed to be 0.85. PAEE was
calculated as (TEE × 0.9) - REE assuming 10% diet-
induced thermogenesis of TEE.
Physical activity subcomponents and sedentary time
The physical activity subcomponents, time spent in mod-
erate-to-vigorous physical activity, total volume of activ-
ity (accelerometry counts per day) and sedentary time,
were measured using heart rate and accelerometry data
from an Actiheart monitor, a combined heart rate and
movement sensor (CNT Ltd, Papworth, UK). The Acti-
heart was positioned using electrocardiogram electrodes
on the left side of the chest at the level of the heart (I2-I3
level). The monitor was worn day and night during the
same 10-day period as the DLW measurement was per-
formed. Participants were asked to remove the Actiheart
during periods of water immersion such as swimming or
bathing. Only days with > 90% valid heart rate data were
used and a minimum of four days of valid data was
required in order for the analyses to be performed. Total
accelerometry counts adjusted for wear time were used
as an index of total volume of physical activity. Time
spent in moderate-to-vigorous intensity activity was cal-
culated as the percent of wear time with a valid heart rate
greater than 174% of resting heart rate [18]. Sedentary
time was estimated using epochs with valid heart rate
data and zero accelerometry counts per minute and
expressed as a percent of wear time.
Blood analyses
The participants attended the Clinical Research Center
on the morning following an overnight fast (≥10 h).
Capillary plasma glucose was measured on a Hemocue
Glucose 201 Analyzer (Hemocue, Inc., CA, USA) to
ensure that women who had very low or high (i.e. con-
sistent with a diagnosis of diabetes) blood glucose con-
centrations were not exposed to the glucose challenge.
One woman was excluded on the basis of having high
blood glucose levels. A standard 75 g oral glucose toler-
ance test (OGTT) [19] was performed with venous
blood samples drawn prior to the challenge and at 30,
60 and 120 minutes after the glucose load. Serum insu-
lin concentrations were determined by microparticle
enzyme immunoassay (Abbott Imx, Abbott Laboratories,
Abbott Park, IL) and glucose levels were analyzed using
on VITROS 5,1 FS Chemistry System (Ortho-Clinical
Diagnostics, Raritan, NJ) at the clinical biochemistry
laboratory at Umeå University Hospital. Additional
venous blood was drawn into EDTA-plasma and serum
tubes and stored at -80°C for later analyses.
Estimates of insulin sensitivity and b-cell response
We calculated the insulin sensitivity index (ISIOGTT) from
the OGTT using the composite model of Matsuda [10000/
√(Glu0 *I n s 0) * (Glumean *I n s mean)] which has been shown
to be strongly correlated with insulin sensitivity measured
by the hyperinsulinemic-euglycemic clamp during
pregnancy [20]. The Stumvoll first-phase insulin response,
calculated as [1,194 + (4.724*Ins0) - (117.0*Glu60)+
(1.414*Ins60)] has been used previously in pregnant women
[21]. b-cell function was estimated using oral disposition
index (DIO)c a l c u l a t e da s[ ( ΔIns 0-30/ΔGlu 0-30) × 1/fasting
insulin] [22]. Insulin area under the curve (IAUC) and glu-
cose area under the curve (GAUC) were calculated using
the trapezoidal method.
Self-reported pain
To compare pain in pregnant and non-pregnant women,
participants were asked about general pain using a ques-
tionnaire. Participants were asked to rate pain during the
past four weeks as well as the extent to which pain inter-
fered with daily activities. Participants could report none,
very little, light, moderate, or severe pain during the past
four weeks (i.e. regarding pregnant women: during gesta-
tional weeks 24-28). Participants could also report that
the pain interfered not at all, a little, moderately, or very
much with daily activity (including physical activity).
Statistical analyses
Participant characteristics are given as means and stan-
dard deviations, or as medians and interquartile range
for non-normally distributed data. Comparisons between
pregnant and non-pregnant women were made with t-
tests or in the case of non-normally distributed data,
with Wilcoxon-Mann-Whitney tests. Differences in sub-
jective assessments of pain and the impact of pain on
daily activity were assessed with Cochran-Armitage
Trend tests. Insulin sensitivity or b-cell response esti-
mates and physical activity subcomponents were
adjusted for age prior to comparisons. Partial r
2 values
were calculated from linear regression. Logarithmic
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bution when necessary. Correlations were assessed with
Spearman correlations. Differences in the correlations
between the physical activity subcomponents and the
insulin sensitivity and secretion variables were compared
with tests of the equality of correlation coefficients for
independent samples [23]. All statistical analyses were
performed using SAS (SAS v9.2, Cary, NC).
Results
Participant characteristics are shown in Table 1. Thirty-
five pregnant women and 73 non-pregnant women
entered the study. Energy expenditure data from DLW
were unavailable for three women (all non-pregnant).
Two pregnant women dropped out during the course of
the study and valid Actiheart data could not be retrieved
from the monitors for one pregnant woman and one
non-pregnant woman, thus 32 pregnant and 69 non-
pregnant women had complete datasets. The pregnant
women were significantly older than the non-pregnant
women. REE was significantly higher in pregnant
women. The two groups did not differ significantly in
height, weight, BMI, or in other estimates of body com-
position (percent body fat, fat mass, or fat-free mass).
Self-reported pain
Pregnant women did not differ from non-pregnant
women in self-reported severity of pain during the pre-
vious four weeks, although the test for difference
approached statistical significance (p = 0.051 for trend).
Pregnant women reported that pain did interfere with
daily activity to a greater extent than non-pregnant
women (p < 0.0001 for trend).
Physical activity subcomponents
Table 2 shows the descriptive statistics and comparisons
of physical activity subcomponents between pregnant and
non-pregnant women. Sedentary time was significantly
higher in pregnant than in non-pregnant women. PAEE,
time spent in moderate-to-vigorous intensity activity and
total activity were significantly lower in pregnant com-
pared with non-pregnant women.
Insulin and glucose measures
Table 2 shows the insulin and glucose measures used to
calculate the estimates of insulin sensitivity and b-cell
response. At fasting, 30, 60, and 120 minutes post glucose
load, insulin levels were significantly higher in pregnant
women than in non-pregnant women. Fasting glucose
was significantly lower in pregnant women, but at 30, 60,
and 120 minutes post-load glucose was not significantly
different between pregnant and non-pregnant women.
Pregnant women had significantly higher incremental
insulin and mean insulin levels, and a larger glucose area
under the curve than non-pregnant women.
Insulin sensitivity and b-cell response estimates
Estimated first-phase insulin response was significantly
h i g h e ri np r e g n a n tw o m e nt h a ni nn o n - p r e g n a n t
women (p = 0.035). Insulin sensitivity index (ISIOGTT)
was significantly lower in pregnant women (p = 0.016).
There were no significant differences in b-cell function
in relation to insulin sensitivity during an oral glucose
challenge (DIO) (p = 0.72).
Physical activity subcomponents and measures of insulin
sensitivity and secretion
The correlations and partial r
2 values between total
activity, PAEE, moderate-to-vigorous intensity time,
sedentary time, and the measures of b-cell response and
insulin sensitivity are shown in Table 3. Only total activ-
ity was significantly associated with any of the estimates
of insulin sensitivity or b-cell response. Total activity
was significantly positively correlated with ISIOGTT in
non-pregnant women and was significantly negatively
correlated with first-phase insulin response in both
pregnant and non-pregnant women. In tests of equality
of correlations comparing pregnant and non-pregnant
women, the correlations did not differ significantly for
any comparison between physical activity subcompo-
nents and measures of insulin sensitivity or secretion.
Discussion
This is the first study to our knowledge to use gold-stan-
dard methods to assess relationships between physical
activity and glucose and insulin dynamics in pregnancy.
Our main findings are that although the levels of physical
activity differ between pregnant and non-pregnant
women, with the latter being most active, the impact
of physical activity on estimated insulin sensitivity and
b-cell response did not differ between groups. These
findings are important, because they highlight specific
Table 1 Demographic and anthropometric characteristics
Pregnant Non-pregnant p-value
a
N3 2 6 9
Age (years) 30.4 (2.9) 28.6 (4.4) 0.013
Height (m) 1.67 (0.06) 1.67 (0.07) 0.750
Weight (kg) 76.1 (14.1) 76.7 (19.2) 0.809
BMI (kg/m
2) 27.4 (5.0) 27.4 (6.5) 0.987
Fat mass (kg) 26.4 (11.0) 29.2 (14.7) 0.281
Fat-Free mass (kg) 49.7 (4.7) 47.5 (6.1) 0.067
Body fat (%) 33.6 (6.8) 36.0 (9.3) 0.190
TEE (kJ/day) 11185 (1176) 11068 (1582) 0.706
REE (kJ/day) 6685 (749) 6229 (825) 0.007
Statistics are means (standard deviations).
ap-value for t-test comparing
differences between pregnant and non-pregnant women. Measurements
in the pregnant women were at gestational weeks 28-32.
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upon and that are likely to promote improvements in
aw o m a n ’s insulin and glucose dynamics during preg-
nancy, thus aiding in the prevention of GDM.
Consistent with studies published elsewhere, we found
that insulin sensitivity is lower during pregnancy and b-
cell response is higher [24]. We also found that, com-
pared with non-pregnant women, pregnant women were
less active as measured by most of the subcomponents
of physical activity. Specifically, pregnant women
engaged in less total activity, had lower PAEE, spent less
time undertaking moderate-to-vigorous intensity activity,
and spent more time sedentary. A key finding of our
study is that despite the differences in physical activity,
insulin sensitivity, and b-cell response, the associations
between the physical activity subcomponents and insulin
sensitivity and b-cell response do not appear to differ
significantly in pregnant versus non-pregnant women.
Therefore, it is likely that maintaining total physical
activity through behaviors such as daily walking and
limiting sedentary time has similar beneficial effects on
glucose metabolism in pregnant women as in non-preg-
nant women.
An insufficient increase in b-cell response to compen-
sate for the decline in insulin sensitivity, which is typical
in pregnancy, is a risk factor for GDM [21]. In the pre-
sent study of women with normal glucose tolerance,
pregnant women had a higher b-cell response and a
lower level of insulin sensitivity. Accelerometry counts
per day, a measure of total physical activity, was posi-
tively related to insulin sensitivity and negatively related
to b-cell response. These relationships were not signifi-
cantly different in pregnant versus non-pregnant
women. Insulin response relative to insulin sensitivity
during an OGTT (DIO)w a sn o ts i g n i f i c a n t l yd i f f e r e n t
between pregnant and non-pregnant women and no
relations to physical activity subcomponents were
observed. The lack of a statistically significant relation-
ship between DIO and the physical activity measures
suggests that in healthy pregnant women, differences in
physical activity do not result in differences in glucose
tolerance, although it is important to note that our
study was probably underpowered to detect small
effects; as such, we cannot rule out the possibility that
such relationships exist.
Our results suggest that total activity is the most
strongly associated component of physical activity with
measures of insulin sensitivity and b-cell response in
both pregnant and non-pregnant women. Other physical
activity subcomponents such as sedentary time, and
PAEE did not appear to be strongly associated with
measures of insulin sensitivity or response. This is con-
sistent with studies that included only non-pregnant
adults [4]. This suggests that the total volume of activity
both preconception as well as during pregnancy might
be the most important physical activity subcomponent
to emphasize for maintaining normal glucose tolerance
in pregnancy. Longitudinal studies of the subcompo-
nents of physical activity in relation to changes in insu-
lin sensitivity and b-cell response during pregnancy are
needed. Qualitatively, the pregnant women in our study
more frequently reported pain severe enough to disturb
Table 2 Physical activity subcomponents
Pregnant Non-pregnant p-value
a
Physical activity subcomponents
Moderate-to-vigorous time (% weartime) 5.4 (15.3) 18.6 (14.0) < 0.0001
Accelerometry (thousand counts per day) 30.7 (12.0) 54.6 (36.4) < 0.0001
Sedentary time (% weartime) 55.5 (11.9) 49.2 (10.7) < 0.0001
PAEE (kcal/day) 812 (235.4) 924 (296) 0.045
Insulin and glucose variables
Fasting Glucose (mmol/L) 4.0 (0.5) 4.4 (0.5) < 0.0001
30 Minute Glucose (mmol/L) 6.1 (1.5) 6.4 (1.5) 0.2422
60 Minute Glucose (mmol/L) 6.6 (1.8) 5.8 (2.4) 0.2859
120 Minute Glucose (mmol/L) 4.8 (1.6) 5.2 (1.7) 0.392
Mean Glucose (mmol/L) 5.4 (1.1) 5.4 (1.3) 0.3049
GAUC (mmol/L) 186.0 (148.5) 141.0 (180.0) 0.0461
Fasting Insulin (pmol/L) 50.0 (42.4) 34.0 (34.0) 0.0021
30 Minute Insulin (pmol/L) 444.5 (243.1) 305.6 (222.2) 0.0069
60 Minute Insulin (pmol/L) 562.5 (382.0) 319.5 (229.2) 0.0004
120 Minute Insulin (pmol/L) 46.0 (36.0) 27.0 (24.0) 0.012
Mean Insulin (pmol/L) 336.1 (202.8) 201.4 (143.8) 0.0026
IAUC (pmol/L) 6049.5 (3298.5) 3710.3 (2974.5) 0.0031
Descriptive statistics are medians (interquartile range); PAEE, physical activity energy expenditure; GAUC, incremental glucose area under the curve; IAUC,
incremental insulin area under the curve.
ap-value for Wilcoxon-Mann-Whitney test comparing differences between pregnant and non-pregnant women.
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Moderate-to-Vigorous Time (% of
weartime)
Total activity (counts/day) Sedentary Time (% of weartime) PAEE (kcal/day)
Pregnant Non-pregnant Pregnant Non-pregnant Pregnant Non-pregnant Pregnant Non-pregnant
Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI) Partial
r
2
r (95% CI)
ISIOGTT 0.004 0.10 0.034 0.25 0.048 0.28 0.221 0.46 0.0003 -0.06 0.004 0.04 0.02 0.12 0.0002 -0.01
(-0.16 to
0.34)
(-0.11 to
0.56)
(-0.07 to
0.57)
(0.24 to
0.64)
(-0.40 to
0.29)
(-0.21 to
0.29)
(-0.23 to
0.44)
(-0.24 to
0.24)
First phase insulin
response
0.0003 -0.07 0.044 -0.16 0.108 -0.47 0.106 -0.36 0.009 0.17 0.004 -0.13 0.037 -0.22 0.011 -0.16
(-0.41 to
0.29)
(-0.40 to
0.10)
(-0.70 to
-0.15)
(-0.56 to
-0.12)
(-0.18 to
0.49)
(-0.38 to
0.11)
(-0.52 to
0.12)
(-0.39 to
0.07)
DIo 0.005 0.03 0.001 0.02 0.021 0.24 0.007 0.10 0.002 0.25 0.0005 0.02 0.004 -0.10 0.0005 0.04
(-0.33 to
0.38)
(-0.23 to
0.28)
(-0.12 to
0.54)
(-0.16 to
0.34)
(-0.10 to
0.55)
(-0.23 to
0.27)
(-0.42 to
0.25)
(-0.20 to
0.28)
R-values are Spearman correlation coefficients. All correlations partialled for age, PAEE additionally partialled for weight. Partial r
2 are from multiple linear regressions including age, and for PAEE, age and weight as
covariates. PAEE, physical activity energy expenditure; ISIOGTT, Matsuda composite insulin sensitivity index; DIO, oral disposition index. Bold text indicates a statistically significant (p < 0.05) correlation.
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8normal daily activity, which may well help explain why
pregnant women were often less active than non-preg-
nant women. Thus, interventions that also focus on cop-
ing with pregnancy-related pain may further enhance
activity levels, and hence indirectly benefit the health of
the woman.
In a separate analysis testing the validity of a wrist-
worn accelerometer (GENEA, Unilever Discover, UK) in
this cohort, REE, PAEE, and accelerations (as measured
by that monitor) were not significantly different in preg-
nant versus non-pregnant women (Van Hees et al,
unpublished). This differed from our finding that PAEE
and REE were significantly different in pregnant and
non-pregnant women (p = 0.045 and p = 0.007, respec-
tively), which is due to slight differences in the study
sample. The Van Hees et al analysis included six fewer
participants (4 non-pregnant and 2 pregnant) due to an
absence of critical measurements that were the central
feature of that study. Nevertheless, when these partici-
pants are excluded from our analysis the differences in
moderate-to-vigorous time, sedentary time, and total
activity remained statistically significant (data not
shown).
This study is the first to our knowledge to incorporate
very detailed objective measures of physical activity dur-
ing pregnancy and compare these with well-character-
ized glucose regulation phenotypes. Our study also has
limitations; first, the cross-sectional nature of the com-
parisons between physical activity subcomponents and
estimates of insulin sensitivity and b-cell response
makes it impossible to determine the direction of caus-
ality in the relationships we report. A second limitation
is that because we used a range of very detailed mea-
surement methods that are infeasible for use in large
s a m p l ec o l l e c t i o n s ,t h es t u d ys a m p l ei sr e l a t i v e l ys m a l l ,
which means that the detection of small effects in this
study, whilst not impossible, may be unlikely.
Conclusion
In summary, we have conducted an intensively pheno-
typed study of pregnant and non-pregnant women to
investigate the relationships between physical activity
subcomponents and estimates of insulin sensitivity and
secretion. A key finding of this study is that, as pre-
viously established in non-pregnant women, total physi-
cal activity is positively associated with estimated insulin
sensitivity during pregnancy. This in turn suggests that
increased habitual physical activity at any intensity
(rather than increased moderate-to-vigorous time) may
be a means to help control glucose homeostasis during
pregnancy. Appropriately designed intervention studies
are required to determine whether these relationships
are causal.
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